Cite
Bergen ES, Binter A, Starzer AM, et al. Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. Ther Adv Med Oncol. 2021;13:17588359211009002doi: 10.1177/17588359211009002.
Bergen, E. S., Binter, A., Starzer, A. M., Heller, G., Kiesel, B., Tendl-Schulz, K., Bago-Horvath, Z., Furtner, J., Leitner, J., Exner, R., Fitzal, F., Dieckmann, K., Widhalm, G., Preusser, M., Berghoff, A. S., & Bartsch, R. (2021). Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. Therapeutic advances in medical oncology, 1317588359211009002. https://doi.org/10.1177/17588359211009002
Bergen, Elisabeth Sophie, et al. "Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab." Therapeutic advances in medical oncology vol. 13 (2021): 17588359211009002. doi: https://doi.org/10.1177/17588359211009002
Bergen ES, Binter A, Starzer AM, Heller G, Kiesel B, Tendl-Schulz K, Bago-Horvath Z, Furtner J, Leitner J, Exner R, Fitzal F, Dieckmann K, Widhalm G, Preusser M, Berghoff AS, Bartsch R. Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. Ther Adv Med Oncol. 2021 Apr 22;13:17588359211009002. doi: 10.1177/17588359211009002. eCollection 2021. PMID: 33995593; PMCID: PMC8072867.
Copy
Download .nbib